This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Incyte Corporation. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Michael Kuligowski: Innovator in Dermatological Treatments
Introduction
Michael Kuligowski is a notable inventor based in Chadds Ford, PA (US). He has made significant contributions to the field of dermatology, particularly in the treatment of atopic dermatitis. With a total of 4 patents to his name, Kuligowski's work focuses on innovative formulations that aim to improve patient outcomes.
Latest Patents
Among his latest patents is a formulation of ruxolitinib designed for the reduction of itch in patients suffering from atopic dermatitis. This disclosure outlines methods for alleviating itch and treating the condition by administering a topical cream containing either 0.75% or 1.5% ruxolitinib twice daily. This formulation represents a significant advancement in the management of atopic dermatitis, providing relief to patients who struggle with this chronic condition.
Career Highlights
Michael Kuligowski is currently associated with Incyte Corporation, a leading biopharmaceutical company. His role at Incyte allows him to leverage his expertise in dermatological treatments and contribute to the development of innovative therapies. His work has been instrumental in advancing the understanding and treatment of skin conditions.
Collaborations
Kuligowski collaborates with talented professionals in his field, including May Grace E Venturanza and Kang Sun. These collaborations enhance the research and development efforts at Incyte Corporation, fostering an environment of innovation and discovery.
Conclusion
Michael Kuligowski's contributions to dermatology through his innovative patents and collaborations highlight his commitment to improving patient care. His work continues to pave the way for advancements in the treatment of atopic dermatitis and other skin conditions.